Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine versus placebo for prevention of platinum chemotherapy-induced neurotoxicity
NL-OMON29356Not yet recruiting
- Sponsor
- Rijnstate
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC) and mesothelioma comparing N-acetylcysteine arm with Placebo arm (2 arms). Primary endpoint: Occurrence of peripheral neuropathy. Planned start Jan 2008; status: not yet recruiting.
02
Drugs
acetylcysteine
03
Conditions
non-small cell lung cancer (NSCLC)small cell lung cancer (SCLC)mesothelioma
Beyond the preview
Go deeper on NL-OMON29356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON29356.